Children’s Hospital Los Angeles has received significant interest and inquiries about recent incidents of a Kawasaki Disease (KD)-like syndrome which we are now referring to as PIMS, shorthand for Pediatric Inflammatory Multisystem Syndrome, including its relationship to COVID-19.
To support your practice, CHLA has made the multi-disciplinary team overseeing our KD/PIMS approach available to you during a one-hour session. This session included an overview of our diagnostic, testing and referral strategies, as well as plenty of time for you to raise questions regarding what you are seeing in the community.
Although there are very few children across the U.S. currently diagnosed with this condition, delays in treatment cause devastating results for the children that we are seeing. We want to ensure that you are armed with what you need to care for children in your practice and answer questions you may be receiving from anxious parents.
It is now being referred to by health authorities as Multisystem Inflammatory Syndrome in Children, or MIS-C.
KAWASAKI-LIKE DISEASE RELATED TO COVID-19
PHYSICIAN INFORMATIONAL SESSION
MAY 13, 2020
CHILDREN’S HOSPITAL LOS ANGELES SPECIALISTS PRESENTING:
James Stein, MD, MSc, FACS, FAAP
Chief Medical Officer, Children’s Hospital Los Angeles
Associate Professor of Clinical Surgery, Keck School of Medicine of USC
Jacqueline Szmuszkovicz, MD
Pediatric Cardiologist, Specialist in Kawasaki Disease, Children’s Hospital Los Angeles
Associate Professor of Pediatrics, Keck School of Medicine of USC
Attending Cardiologist, Heart Institute, Children's Hospital Los Angeles